John Rossi, Nassim Usman, Craig Mello, Gary Ruvkun, and Wolfgang Fries | GenomeWeb

This year’s American Association of Pharmaceutical Scientists National Biotechnology Conference will feature two speakers from the RNAi field.

John Rossi, from the City of Hope’s Beckman Research Institute, is scheduled to present his preclinical work on treating HIV using RNAi.

Sirna Therapeutics’ COO Nassim Usman is also slated to discuss his company’s work using RNAi to treat age-related macular degeneration.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.